Beyond the operating room: what can twenty years of experience in ischemic mitral regurgitation teach us?
Original article comparing long-term survival according to residual mitral regurgitation, completeness of revascularization, and ventricular remodeling among patients undergoing mitral valve repair with restrictive annuloplasty and concomitant coronary artery bypass grafting for chronic ischemic mitral regurgitation, based on two decades of single-center follow-up.
Can a new robot-assisted mitral valve surgery program achieve excellence from its earliest cases?
Retrospective analysis presenting a single-center experience with the first 100 cases of a robotic mitral valve program
More than 1000 patients with a Fontan circulation: a snapshot of current reality
First cross-sectional analysis from a multicenter prospective registry of the Fontan Outcomes Network (FON), enrolling patients with a Fontan circulation between 2022 and 2024 at centers across the United States and Canada, with particular attention to their demographic, clinical, and imaging characteristics, as well as associated comorbidities.
Total or partial pericardiectomy? a decision that continues to shape prognosis
Study comparing the outcomes of anterior interphrenic pericardiectomy versus the extended technique supported by cardiopulmonary bypass (CPB).
Success of surgical left atrial appendage closure: are we getting it right?
Systematic review aimed at identifying and describing the imaging modalities, evaluation criteria, and validation methods used to assess the success of surgical left atrial appendage closure.
Three months of dual antiplatelet therapy after coronary revascularisation: sufficient protection with lower bleeding risk?
A randomised, multicentre, double blind trial across thirteen hospitals in China comparing ticagrelor plus aspirin dual antiplatelet therapy for three versus 12 months in patients undergoing coronary artery bypass grafting with at least one saphenous vein graft.
Getting there first or getting there better? escalation of circulatory support before definitive ventricular assist
European multicentre study comparing strategies when the Impella CP® microaxial flow pump falls short: staying the course or escalating to the Impella 5.5®.
When survival is no longer enough: from surgical success to patient success in single-ventricle disease
Study and accompanying editorial examining therapeutic goals in the Norwood operation, comparing early outcomes of the two initial pulmonary blood flow strategies: the modified Blalock-Taussig-Thomas shunt (MBTTS) and the right ventricle-to-pulmonary artery shunt (RVPAS).
